Both in Pharmaceuticals
Skye Bioscience vs CNS Pharmaceuticals
Over the past year SKYE returned −94.9% and CNSP returned −44.8%; their daily moves had a correlation of 0.00.
SKYE −94.9% CNSP −44.8%Growth of $1, one year, split-adjusted
| Metric | SKYE | CNSP |
|---|---|---|
| Price | $1.59 | $4.91 |
| Market cap | $7.0M | $7.2M |
| Today | −1.24% | −3.97% |
| 1 month | −10.4% | −11.1% |
| 6 months | −66.5% | +116.2% |
| Year to date | −73.5% | −6.5% |
| 1 year | −95.2% | −44.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | $20.0M |
| Dividend yield | — | — |
| Volatility (60d) | 616.5% | 74.8% |
| Short % of float | 0.5% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).